Загрузка...
Clinical predictor of survival following docetaxel-based chemotherapy
Prostate cancer (PCa) is the most common type of cancer in males in the USA and the incidence is increasing. For castration-resistant PCa (CRPC), previous studies have identified docetaxel-based chemotherapy as the first-line therapy. In the present study, the efficacy of docetaxel-based chemotherap...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4156217/ https://ncbi.nlm.nih.gov/pubmed/25202411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2349 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|